NUCALA Mepolizumab Injection Single Dose Vial
- NUCALA is an interleukin-5 (IL-5) antagonist monoclonal antibody (IgG1 kappa) indicated for: Add-on maintenance treatment of patients with severe asthma aged 6 years and older, and with an eosinophilic phenotype. \n
- NUCALA is an interleukin-5 (IL-5) antagonist monoclonal antibody (IgG1 kappa) indicated for: The treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). \n
- NUCALA is an interleukin-5 (IL-5) antagonist monoclonal antibody (IgG1 kappa) indicated for: The treatment of adult and pediatric patients aged 12 years and older with hypereosinophilic syndrome (HES) for ?6 months without an identifiable non hematologic secondary cause. \n
- Requires Refrigeration
- Dosage form:
- injection
- NDC number:
- 0173-0881-01
- Type:
- subcutaneous
- Manufacturer:
- Glaxosmithkline
- Mckesson #:
- 1184533
- Brand:
- Nucala
- UNSPSC:
- 51202400
- Application:
- interleukin-5 (il-5)
- Generic drug name:
- mepolizumab
- Container type:
- single dose vial
- Manufacturer #:
- 00173088101
- Product dating:
- mckesson acceptable dating: we will ship >= 90 days
- Storage requirements:
- usp controlled room temperature
